Yes. Naproxen can help headaches and migraines, but its usefulness depends on the headache type, how early it is taken, and the dose form used. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that lowers prostaglandin production. That matters most when a headache is driven by inflammation or by prostaglandin-sensitive dilation of cranial blood vessels. Migraine attacks respond in many people when the drug is taken early. Tension-type headaches often respond as well. The evidence is weaker for frequent or chronic daily headache, and naproxen is not a substitute for a diagnosis when headaches are new, severe, or changing.
How Naproxen Interrupts a Headache
Naproxen works by blocking two enzymes, cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Both enzymes convert a fatty acid called arachidonic acid into prostaglandin precursors. Prostaglandins are short-lived signaling molecules that sensitize pain nerve endings and promote vasodilation. Blocking COX lowers prostaglandin output, so pain fibers in the meninges and blood vessels around the skull become less excitable.
Migraine involves more than prostaglandins. During an attack, the trigeminal nerve releases calcitonin gene-related peptide (CGRP), which dilates cranial vessels and amplifies pain signaling. Prostaglandins contribute to that sensitization. Naproxen does not block CGRP directly. It reduces the prostaglandin component of the cascade, which is one reason it works better early in an attack than after central sensitization has set in.
Naproxen sodium is absorbed faster than naproxen base. The sodium salt reaches peak blood levels in roughly one to two hours, while the base form peaks more slowly. That absorption difference is why naproxen sodium is the form most often studied for acute headache. The drug's long half-life, roughly 12 to 17 hours, means one dose can cover a long window, but it also means repeated dosing accumulates.
What the Numbers Show for Migraine and Tension-Type Headache
Naproxen sodium has been studied as an acute migraine treatment in randomized trials. In a placebo-controlled trial published in 2002, a 550 mg dose produced meaningful pain relief in a substantially larger share of patients than placebo within two hours. The same trial tested a 825 mg dose and found relief rates higher still. These are single-trial figures, not universal response rates, and individual results vary widely.
Naproxen is also used as a short-term preventive bridge in menstrual migraine, where attacks cluster around menstruation. The logic is timing: a scheduled course covers the predictable high-risk window rather than waiting for pain to start. This is a clinician-directed strategy, not a self-directed one.
For tension-type headache, NSAIDs including naproxen are among the medications with the best evidence for acute relief. The effect is modest but real. The drug is less useful when headache is constant and low-grade rather than episodic and pressure-like.
Timeline of a Treated Attack
| Time after dose | What happens | Clinical implication |
|---|---|---|
| 0–15 min | Tablet begins dissolving in the stomach | Food can slow this step |
| 30–60 min | Absorption into blood begins | Taking it early matters more than perfect timing |
| 1–2 h | Peak levels for naproxen sodium | Relief usually becomes apparent here |
| 2–4 h | Full effect on prostaglandin synthesis | Partial relief is common, not failure |
| 4–12 h | Drug persists at declining levels | Long half-life covers a long window |
| 12–17 h | Roughly half the drug cleared | Repeat dosing accumulates |
| 24 h+ | Continued slow clearance | Daily use raises gastrointestinal risk |
This table describes typical pharmacokinetics, not a dosing schedule. It shows why early treatment beats late treatment. Once a migraine attack has progressed to central sensitization, usually over one to several hours, prostaglandin blockade addresses only part of the pain system.
Edge Cases That Change the Answer
Several situations make naproxen a poor or unsafe choice. People with peptic ulcer disease, prior gastrointestinal bleeding, or kidney impairment face elevated risk. NSAIDs reduce renal blood flow, which matters in dehydration, older age, and heart failure. People taking anticoagulants or antiplatelet drugs face added bleeding risk.
Aspirin-exacerbated respiratory disease is a specific trap. People with this condition react to all nonselective NSAIDs, including naproxen, with bronchospasm and severe nasal symptoms. The reaction is to the COX-1 blockade itself, so switching NSAIDs does not solve it.
Pregnancy is another boundary. NSAID use in late pregnancy is linked to fetal circulation problems and premature closure of a vessel in the fetal heart. Clinicians generally avoid NSAIDs in the third trimester. This is a discussion for a prescriber, not a self-management decision.
Children and adolescents deserve caution. NSAIDs are used in pediatric migraine under clinician guidance, but dosing and diagnosis differ from adults. Reye syndrome concerns apply to aspirin, not naproxen, but the diagnostic stakes in a child with a new severe headache are high.
Red Flags That Override Any Drug Decision
A sudden, severe headache reaching peak intensity within seconds to a minute. Headache with fever, stiff neck, confusion, weakness, or vision loss. New headache after age 50, or a change in a long-standing headache pattern. Headache after head injury, or one that worsens with coughing, straining, or lying down. Daily headache needing pain relievers on most days for weeks.
These warrant urgent evaluation, not a trial of naproxen.
Misconceptions Worth Correcting
The most common misconception is that a stronger NSAID works better for every headache. Naproxen is longer-acting than ibuprofen, not inherently more powerful. Ibuprofen has a shorter half-life and a faster onset in some formulations. For a short, sharp tension headache, ibuprofen may be adequate. For a long migraine, naproxen's duration can be an advantage.
Another misconception is that naproxen prevents migraine. It is not a preventive drug in the way beta-blockers, topiramate, or CGRP monoclonal antibodies are. It can be used as a short-term bridge in predictable windows, but daily use is a different risk profile entirely.
A third misconception involves medication-overuse headache. Regular use of acute pain relievers, including naproxen, can paradoxically increase headache frequency. The threshold commonly cited is use on 10 or more days per month for simple analgesics and 15 or more days per month for combination analgesics, sustained over three months. A professional caveat: the exact boundary varies by guideline and by drug class, so the practical rule is fewer headache days on medication, not a precise number.
A counterintuitive detail: naproxen's long half-life that helps with a long migraine also makes it easier to accumulate. Taking it on consecutive days for a persistent headache can quietly build exposure.
Comparison With Other Acute Options
| Option | Class | Typical onset | Duration | Key trade-off |
|---|---|---|---|---|
| Naproxen sodium | NSAID | 1–2 h | Long | GI and kidney risk with repeat use |
| Ibuprofen | NSAID | 30–60 min | Short | Shorter coverage, similar GI risk |
| Acetaminophen | Analgesic | 30–60 min | Short | Liver risk at high doses |
| Triptan | Serotonin agonist | 30–120 min | Moderate | Prescription, cardiovascular cautions |
| Aspirin | NSAID | 30–60 min | Moderate | Bleeding risk, respiratory reactions |
| Caffeine combination | Adjunct | Variable | Short | Overuse risk, rebound |
This table shows a spectrum, not a ranking. Triptans target the CGRP pathway and are often more effective for moderate to severe migraine than NSAIDs. Naproxen remains a reasonable first step for mild to moderate attacks and for people who cannot take triptans.
Practical Actions Before and After Taking Naproxen
Take the drug as early as possible in an attack, ideally within the first hour of pain. Waiting for pain to peak reduces the chance of full relief. Use the lowest effective dose for the shortest time, and avoid combining with other NSAIDs.
Track headache days and medication days for at least a month. If you use acute pain relievers on more than 10 days per month, that pattern needs clinical review. The number is a signal, not a diagnosis.
Take naproxen with food or milk if stomach upset occurs. Avoid alcohol with it, because both irritate the stomach lining. Stay hydrated, because NSAIDs reduce kidney blood flow and dehydration compounds that.
Do not use naproxen for headache during pregnancy, especially the third trimester, without a prescriber's input. Do not use it in children without clinician guidance. Do not use it if you have had a prior ulcer or gastrointestinal bleed unless a clinician has specifically approved it.
Keep a simple log: date, headache type, time of onset, time of dose, relief at two hours, and any side effects. That record is more useful to a clinician than a general report of "it sometimes helps."
If headaches occur more than four days per month, or if acute treatment fails repeatedly, the conversation should shift from which pain reliever to what underlying pattern needs treatment. Frequent use of acute medication is a reason to seek evaluation, not to escalate self-treatment.
The practical boundary is simple. Naproxen helps episodic headaches when taken early and used sparingly. It does not fix a headache pattern that keeps returning, and it carries real risks when used as a daily habit. Matching the drug to the headache type and to the person's health profile is the part that matters most.